Friday, June 18, 2010

Tevron Solutions Fully Support all Eclipsys Applications

Nashua, New Hampshire, June 17, 2010 - Tevron today announced the addition of support for all Eclipsys environments to its suite of APM & Testing solutions. Eclipsys (Nasdaq: ECLP) is a leader in delivering advanced healthcare IT solutions that make a tangible difference in quality, safety and cost-effectiveness. With the latest releases of CitraTest, CitraTest APM, and CitraTest VU, Tevron again is taking the lead role in the APM & testing industry in providing support for every Eclipsys application including Sunrise Clinical Manager, Access Management, Revenue Cycle Management, HealthXchange, PeakPractice EHR/PM, and more. As many hospitals, healthcare systems, clinics, and physician practices move toward Eclipsys, Tevron’s APM & testing solutions will continue to offer the industry lead for application monitoring, load testing, and general automation for those critical deployments.

To learn more about Tevron’s automated testing & monitoring solutions or to request additional information, please call +1.702.518.7435, email sales@tevron.com or visit www.tevron.com.

ABOUT TEVRON

Tevron® is a global leader in APM and Automated Testing. Through our all encompassing customer-centric vision and advanced technology, our APM & Testing Solutions allow the unique flexibility of supporting every application across the enterprise with one methodology delivering the ability to test, monitor, enforce SLAs, and optimize performance with confidence and ease. Founded in 2001, Tevron® is a global organization and is privately held. Our vast and diverse ranges of customers are global leaders and include companies such as Alcon Labs, Alverno, Northrop Grumman, Xerox, Hewlett Packard, Siemens, and Lucent Technologies, to name a few.

TRADEMARKS

Tevron, the Tevron logo, and CitraTest are registered trademarks of Tevron, LLC. Eclipsys is a registered trademark of Eclipsys. All other product references herein are either trademarks or registered trademarks of their respective owners.

No comments: